Copaifera langsdorffii (Fabaceae) Copaiba, Copaíba
Copaifera langsdorffii is a large tree of the Brazilian cerrado and gallery forests, whose trunk exudes an oleoresin known as copaiba balsam, one of the most widely used natural remedies in Amazonian and Brazilian folk medicine for inflammatory conditions, wound healing, and a range of internal and external ailments . The species is the subject of a substantial preclinical literature, with the oleoresin demonstrating gastroprotective, wound-healing, antipsoriatic, and anti-inflammatory activities in animal models and preliminary human observations, while leaf extracts have yielded flavonoids and methoxy-galloylquinic acid derivatives with antioxidant and chemopreventive potential . A Phase I dose-escalation clinical trial of a copaiba-based mouthwash has been conducted in patients undergoing hematopoietic stem cell transplantation, and a Phase II randomized trial is registered, though results are not yet available . The name Copaifera langsdorffii Desf. is the currently accepted binomial, with no recent generic transfer requiring a title update .
1. Taxonomic Insights
Species: Copaifera langsdorffii Desf.
Family: Fabaceae (Leguminosae, subfamily Detarioideae)
Genus: Copaifera
Basionym: Copaifera langsdorffii Desf., Mémoires du Muséum d'Histoire Naturelle 7: 377 (1821)
Synonyms: Copaiba langsdorffii (Desf.) Kuntze
Nomenclatural note: The species was described by Desfontaines in 1821 and is accepted by Kew Plants of the World Online . Three varieties are recognized in the Brazilian Flora: var. langsdorffii, var. glabra (Vogel) Benth., and var. grandifolia Benth., distinguished by leaflet indumentum, leaf rachis length, and sepal pubescence . The species is the most widely distributed and most studied member of the genus in Brazilian medicinal literature .
Botanical Description
Copaifera langsdorffii is a large tree reaching 3 to 15 metres in height (var. langsdorffii) or up to 20 metres (var. glabra and var. grandifolia), with brown, rough, deeply fissured bark and a creamish-pale orange slash. The crown is dense and elegant with open branching. Leaves are paripinnate with 3 to 5 pairs of coriaceous leaflets. The trunk produces a clear oleoresin exudate from natural or artificial cuts, which accumulates in cavities within the trunk . The oleoresin, known as copaiba balsam, consists of an essential oil and a resinous fraction, with the essential oil comprising approximately 8 percent .
Distribution: Native from Guyana through Brazil, Bolivia, Paraguay, and Argentina (Misiones). Introduced to Sri Lanka. It grows in the seasonally dry tropical biome, occurring in cerrado, gallery forests, and dry forests from Tocantins to Paraná in Brazil .
Conservation Status: No formal conservation assessment was identified in the search results. The species is widely distributed and not of immediate concern, though habitat conversion in the cerrado region may pose localized pressures.
Etymology
The generic name Copaifera is derived from the indigenous Tupi name copaíba, meaning "tree that produces oil," referring to the oleoresin exudate. The specific epithet langsdorffii honors Georg Heinrich von Langsdorff (1774–1852), a German-Russian naturalist and explorer who collected in Brazil. Common names include Copaiba, Copaíba, and Copaiba balsam .
2. Common Names
Scientific Name: Copaifera langsdorffii | English: Copaiba, Copaiba Balsam | Portuguese: Copaíba, Pau-de-óleo | Other: Not consistently documented in accessible English-language sources
3. Related Herbs from the Fabaceae Family
Copaifera langsdorffii belongs to the Fabaceae, one of the largest families of flowering plants. Within Copaifera, several species produce oleoresins used in traditional medicine, though C. langsdorffii is the most extensively studied.
Copaifera officinalis: A related species whose oleoresin is also used medicinally and is the species cited in the copaiba mouthwash clinical trial .
Copaifera reticulata: Another Amazonian copaiba species with a similar oleoresin used in folk medicine.
The Fabaceae are characterized by the production of terpenoids, flavonoids, and in Copaifera, the distinctive diterpene acids and sesquiterpenes of the oleoresin.
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions:
Gastroprotective: The oleoresin, administered orally at 200 and 400 mg/kg, provided dose-dependent protection against ethanol- and restraint-stress-induced gastric lesions in rats, and at 400 mg/kg prevented indomethacin-induced ulceration. In pylorus-ligated rats, the oleoresin increased gastric juice volume and mucus secretion while inhibiting total acidity .
Wound healing: Topical application of 4 percent oleoresin accelerated wound contraction in open wounds in rats, with 84.05 percent reduction of original size on day 9 compared with 51.29 percent in controls. Tensile strength in healing incised wounds was significantly higher in the oleoresin-treated group on day 5 (71.48 g/cm versus 35.95 g/cm in controls) .
Secondary Actions:
Anti-inflammatory: The oleoresin and leaf extracts have demonstrated anti-inflammatory activity in experimental models, with the diterpene compound 155 and compound 12 associated with this effect . The oleoresin is used traditionally for inflammatory conditions including sore throat, urinary and pulmonary affections, and skin ulcers .
Antipsoriatic: A preliminary clinical observation reported that three patients with chronic psoriasis treated with oral intake or topical application of the oleoresin exhibited significant improvement in erythema, skin thickness, and scaliness .
Antioxidant and antimicrobial: The oleoresin has demonstrated antioxidant and antibacterial properties in preclinical studies . Leaf extracts have shown antioxidant and chemopreventive potential in experimental models .
Medicinal Parts
Oleoresin (copaiba balsam): The principal medicinal part, obtained by cuts on the stem bark. Used for gastroprotection, wound healing, anti-inflammatory, and antipsoriatic applications .
Leaves: The source of flavonoids (quercitrin, afzelin) and methoxy-galloylquinic acid derivatives with antioxidant potential . Leaf extracts have demonstrated antiedematogenic, antinociceptive, and chemopreventive effects in experimental models .
5. Phytochemistry
5.1 Oleoresin Composition
The oleoresin consists of an essential oil (approximately 8 percent) and a resinous fraction. The essential oil is dominated by sesquiterpenes, with β-caryophyllene reported as a major constituent in some specimens, alongside germacrene D, spathulenol, caryophyllene oxide, and iso-spathulenol . The diterpene fraction contains polyalthic acid, (-)-kaur-16-en-19-oic acid, (-)-16β-kauran-19-oic acid, and eperu-8(20)-en-15,18-dioic acid, along with the sesquiterpene hydrocarbons caryophyllene, copaene, and β-bisabolene . Chemical composition varies significantly with geographic origin and among individual trees within a population .
5.2 Leaf Constituents
The ethyl acetate and water-soluble fractions of the leaf extract furnished the flavonoids quercitrin and afzelin, and the methoxy-galloylquinic acid derivatives 3-O-(3-O-methyl-galloyl)quinic acid, 3,4-di-O-(3-O-methyl-galloyl)quinic acid, 3,5-di-O-(galloyl)-4-O-(3-O-methyl-galloyl)quinic acid, and 3,5-di-O-(3-O-methyl-galloyl)-4-O-(galloyl)quinic acid .
6. Mechanisms of Action
6.1 Gastroprotective: Anti-secretory and Mucus-Enhancing
The gastroprotective mechanism of the oleoresin involves both anti-secretory and cytoprotective components. In pylorus-ligated rats, the oleoresin increased gastric juice volume and mucus secretion while inhibiting total acidity, suggesting enhancement of mucosal defensive factors alongside reduction of aggressive acid secretion .
6.2 Wound Healing: Acceleration of Contraction and Tensile Strength
The wound-healing mechanism was characterized by monitoring wound contraction in excised wounds and tensile strength in healing incision wounds. The 4 percent oleoresin significantly accelerated contraction on day 9 and increased tensile strength on day 5, indicating effects on both the proliferative and remodeling phases of healing .
6.3 Anti-inflammatory: Diterpene-Mediated Activity
The anti-inflammatory activity has been attributed in part to specific diterpene constituents, with compound 155 and compound 12 identified as associated with this effect. These compounds can occur together in multiple Copaifera species, potentially increasing the pharmacological effect through additive or synergistic mechanisms .
7. Traditional and Ethnobotanical Uses
7.1 Sore Throat, Urinary and Pulmonary Affections
Formulation: Oleoresin in its natural form.
Preparation and Use: The oleoresin is a reputed folk remedy in its natural form for the treatment of sore throat, urinary and pulmonary affections .
Scientific Validation: No controlled studies specific to these indications were identified. The anti-inflammatory activity of the oleoresin provides indirect support.
7.2 Wound Healing and Skin Ulcers
Formulation: Topical application of oleoresin.
Preparation and Use: The oleoresin is used to promote healing of skin ulcers and wounds .
Scientific Validation: The wound-healing activity has been demonstrated in rat models, with significant acceleration of wound contraction and increased tensile strength .
7.3 Rheumatism, Bone Fracture, Epilepsy, and Depression
Formulation: Various preparations.
Preparation and Use: C. langsdorffii is often indicated in Brazilian communities to treat rheumatism, bone fracture, epilepsy, and depression .
Scientific Validation: No pharmacological studies were identified to confirm efficacy for these specific indications. The review authors explicitly note this gap .
7.4 Psoriasis
Formulation: Oral intake or topical application of oleoresin.
Preparation and Use: A preliminary clinical observation reported improvement in three patients with chronic psoriasis treated with oral or topical oleoresin .
Scientific Validation: This is a preliminary observation in three patients, not a controlled trial. It requires confirmation in larger, controlled studies.
8. Healing Recipes, Teas, Decoctions, and Practical Applications
No standardized healing recipes, teas, or decoctions specific to C. langsdorffii were identified in the available search results that meet the threshold for inclusion with appropriate scientific context beyond the traditional uses documented above.
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Gastroprotective: Moderate evidence from in vivo animal studies. The oleoresin demonstrated dose-dependent protection across multiple ulcer models with mechanistic characterization . Human trials are lacking.
Wound healing: Moderate evidence from in vivo animal studies. The 4 percent oleoresin significantly accelerated wound contraction and increased tensile strength . Human trials are lacking.
Antipsoriatic: Preliminary evidence from a three-patient clinical observation . This is hypothesis-generating only.
Anti-inflammatory: Preclinical evidence from in vivo models, with diterpene constituents associated with activity .
Oral mucositis prevention (clinical trial): A Phase I dose-escalation trial of a copaiba-based mouthwash has been conducted, and a Phase II randomized, quadruple-blind trial is registered (NCT07810530) in patients undergoing autologous hematopoietic stem cell transplantation. The trial uses a 15 percent copaiba resin aqueous solution. Results are not yet available .
9.2 Safety and Toxicology Data
The Phase I dose-escalation trial of the copaiba-based mouthwash reported no dose-limiting toxicity at any tested concentration . The Phase II trial excludes patients with reported allergy to copaiba-based compounds . No systematic toxicological studies of the oleoresin or leaf extracts were identified in the search results. No case reports of adverse effects from internal use were found.
10. Safety and Toxicology
10.1 Toxicity Profile
Acute Toxicity: No acute toxicity data were identified for C. langsdorffii oleoresin or extracts.
Clinical Safety: The Phase I trial of the copaiba mouthwash reported no dose-limiting toxicity . The oleoresin has a long history of traditional use, but systematic safety evaluation for internal use has not been conducted.
10.2 Contraindications and Precautions
Pregnancy and Lactation: No data available. Avoid medicinal use in the absence of safety information.
Children: No data available.
Known Hypersensitivity: Individuals with reported allergy to copaiba-based compounds should avoid use .
10.3 Potential Drug Interactions
No specific drug interaction data were identified. Theoretical interactions based on anti-inflammatory or gastroprotective activity cannot be excluded.
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
For oleoresin preparations, β-caryophyllene is an appropriate marker for the sesquiterpene fraction, and polyalthic acid or kaurenoic acid derivatives for the diterpene fraction . For leaf extracts, quercitrin and afzelin can serve as flavonoid markers, and the methoxy-galloylquinic acid derivatives as chemotaxonomic markers .
11.2 Recommended Analytical Methods
Gas chromatography-mass spectrometry (GC-MS) is the standard method for oleoresin profiling and quantification of sesquiterpenes and diterpenes . High-performance liquid chromatography (HPLC) can be used for leaf flavonoid and quinic acid derivative quantification .
11.3 Suggested Specifications
For oleoresin intended for medicinal use, specifications for β-caryophyllene content and total diterpene acid content should be established based on validated batches. Given the documented chemical variability with geographic origin and individual trees, specifications should account for this natural variation .
11.4 Adulteration and Market Quality Concerns
Chemical composition varies significantly with geographic origin and among individual trees, which poses a challenge for quality control and reproducibility . Authentication of oleoresin by GC-MS profiling is advisable. Adulteration with oleoresins from other Copaifera species is possible, though these may have similar chemical profiles.
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Tropical to subtropical; native to seasonally dry tropical biomes.
Habitat: Cerrado, gallery forests, and dry forests .
Soil: No specific data available.
Propagation: No specific data available in the search results.
12.2 Sustainable Harvesting
The oleoresin is obtained by cuts on the stem bark, a renewable exudate that does not require felling the tree. This makes oleoresin harvest potentially sustainable if conducted with appropriate resting periods between harvests. No specific sustainable harvesting protocols were identified.
12.3 Conservation Status
No formal conservation assessment was identified. The species is widely distributed across South America .
12.4 Ecological Role and Sustainability Challenges
No specific ecological role or sustainability challenges were identified in the available search results. The oleoresin harvest is non-destructive, which is favorable for sustainability compared with bark or root harvest.
13. Cultivar and Varietal Comparison
Three varieties are recognized: var. langsdorffii, with pubescent or tomentose sepals and ovary margins; var. glabra, with glabrous sepals and ovary; and var. grandifolia, with larger leaflets and longer rachis . The phytochemical and pharmacological differences among these varieties have not been systematically studied.
14. Research Gaps and Future Directions
14.1 Critical Research Gaps
Clinical Trials: Apart from the Phase I/II oral mucositis program, no controlled clinical trials were identified for the traditional indications, including wound healing, gastroprotection, and psoriasis.
Standardization: The review literature identifies the low comparability between preparations and the scarcity of standardized clinical studies as the principal weakness of the evidence base .
Mechanistic Studies: The molecular mechanisms of the gastroprotective and wound-healing activities have not been characterized beyond the physiological level .
Pharmacokinetics: No absorption, distribution, metabolism, or excretion data exist for any constituent.
14.2 Future Research Priorities
Wound Healing Clinical Development: The animal data on wound contraction and tensile strength are sufficiently supportive to justify clinical evaluation of standardized oleoresin preparations for wound healing.
Gastroprotection Clinical Development: The animal data across multiple ulcer models merit clinical evaluation for functional dyspepsia or ulcer prevention.
Standardized Oleoresin Production: Given the documented chemical variability, development of standardized oleoresin with defined marker content is a prerequisite for credible clinical research .
15. Commercial Applications
15.1 Traditional and Folk Medicine
Copaiba oleoresin is widely traded and used in Brazilian and Amazonian folk medicine for inflammatory conditions and wound healing .
15.2 Cosmetics and Personal Care
The oleoresin is used as a cosmetic ingredient, and its anti-inflammatory and antioxidant properties are of interest for skin care applications .
15.3 Pharmaceutical Development
The oral mucositis mouthwash program represents a pharmaceutical development pathway for copaiba in supportive cancer care .
16. Related Plants for Further Study
Copaifera officinalis: The species used in the copaiba mouthwash clinical trial; comparative studies of oleoresin composition and pharmacology would inform species selection .
Copaifera reticulata: Another Amazonian copaiba species with a similar oleoresin used in folk medicine.
17. Reference Literature
Primary Research
Paiva LAF, et al. Gastroprotective effect of Copaifera langsdorffii oleo-resin on experimental gastric ulcer models in rats. Journal of Ethnopharmacology. 1998;62(1):73-78. This study demonstrates dose-dependent gastroprotection across ethanol, indomethacin, and restraint-stress models, with anti-secretory and mucus-enhancing effects .
Paiva LAF, et al. Investigation on the wound healing activity of oleo-resin from Copaifera langsdorffii in rats. Phytotherapy Research. 2002;16(8):737-739. This study demonstrates accelerated wound contraction and increased tensile strength with 4 percent oleoresin .
GC-MS profiling of the phytochemical constituents of the oleoresin from Copaifera langsdorffii Desf. and a preliminary in vivo evaluation of its antipsoriatic effect. Journal of Ethnopharmacology. 2012. This study provides oleoresin compositional data and a preliminary observation of antipsoriatic effect in three patients .
Flavonoids and methoxy-galloylquinic acid derivatives from the leaf extract of Copaifera langsdorffii Desf. Journal of Agricultural and Food Chemistry. 2015;63(31):6955-6960. This study isolates and characterizes quercitrin, afzelin, and four methoxy-galloylquinic acid derivatives .
Reviews
Copaifera langsdorffii Desf.: A chemical and pharmacological review. South African Journal of Botany. 2021. This review compiles traditional uses (96 health problems across 14 body systems), chemical composition, and biological activities, and identifies research gaps .
Occurrence, chemical composition, biological activities and analytical methods on Copaifera genus—A review. Biomedicine & Pharmacotherapy. 2018. This review covers the genus-level phytochemistry and pharmacology, including the anti-inflammatory constituents of C. langsdorffii .
Clinical Trial Registration
NCT07810530. Study of a Copaiba-Based Mouthwash Combined With Low-Level Laser Therapy in the Prevention of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation. Registered clinical trial, Phase II, randomized, quadruple-blind. A Phase I dose-escalation trial reported no dose-limiting toxicity .
Taxonomic References
Plants of the World Online, Kew Science. Copaifera langsdorffii Desf. Provides accepted name, native range, and synonymy .
Flora do Brasil. Copaifera langsdorffii Desf. Provides varietal taxonomy and morphological descriptions for var. langsdorffii, var. glabra, and var. grandifolia .
18. Disclaimer
Copaifera langsdorffii oleoresin has a long history of traditional use and moderate preclinical evidence for gastroprotective, wound-healing, and anti-inflammatory activities. A Phase I clinical trial of a copaiba-based mouthwash reported no dose-limiting toxicity, and a Phase II trial is registered. However, controlled clinical trials for the traditional indications are lacking.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
The oleoresin has not been systematically evaluated for safety during pregnancy, lactation, or in children. Avoid medicinal use in these populations in the absence of safety data.
Individuals with known allergy to copaiba-based compounds should avoid use.
Chemical composition of the oleoresin varies significantly with geographic origin and among individual trees. Standardized preparations should be used for medicinal applications.
Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments